查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1423201

2024-2032 年生物植入物市場報告（按生物植入物類型、材料、原產地、管理模式、最終用戶和地區）

Bio-Implants Market Report by Type of Bio-Implants, Material, Origin, Mode of Administration, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3個工作天內

價格

2023年全球生物植入物市場規模達1,268億美元。展望未來， IMARC Group預計到2032年市場規模將達到2,427億美元，2024-2032年複合年成長率（CAGR）為7.3%。全球老年人口不斷增加，生物材料、3D 列印和組織工程等醫療技術不斷進步，以及患者對生物植入物益處的認知不斷提高，是推動該市場的一些主要因素。

生物植入物，也稱為生物醫學植入物或醫學植入物，是透過手術植入體內以替代、支持或增強生物結構或功能的裝置或材料。這些植入物旨在與活體組織相互作用，促進整合和相容性，以實現特定的醫療目標。生物植入物在其組成、目的和應用方面存在很大差異。它們通常用於各種醫學領域，包括骨科、心臟病學、牙科、神經病學和美容外科。它們還可以替換受損或功能失調的身體部位或結構。例如，關節置換術（例如髖關節或膝關節植入物）用於恢復關節退化患者的活動能力並減輕疼痛。

不斷增加的老年人口主要推動市場，因為他們經常需要針對各種健康狀況進行醫療干預。生物植入物，例如關節置換和牙科植入物，在恢復老年人的活動能力和提高生活品質方面發揮關鍵作用。此外，生物材料、3D 列印和組織工程等醫療技術的不斷進步，使得創新和複雜的生物植入物的開發成為可能。這些技術提高了植入物的耐用性、功能性和生物相容性。此外，心血管疾病、糖尿病和骨科疾病等慢性疾病的日益普及也增加了對生物植入物的需求。這些植入物通常用於治療、復健和恢復正常身體功能。此外，患者對生物植入物的好處及其在改善健康結果方面的有效性的認知不斷提高，導致對這些醫療設備的接受度和需求不斷增加。

生物植入物市場趨勢/促進因素：

世界各地老年人口不斷增加

全球老年人口的成長是推動生物植入物市場成長的重要驅動力。隨著老年人口的增加，關節退化、心血管疾病和牙齒問題等與年齡相關的疾病的盛行率也隨之上升。生物植入物透過提供關節置換、心臟植入物和假牙等解決方案，在解決這些問題方面發揮著至關重要的作用。因此，提高老年人的生活品質和恢復功能獨立性的需求推動了對生物植入物的需求，從而促進了市場的擴張。此外，隨著醫療技術的進步，這些植入物變得越來越複雜、耐用，並且可以根據患者的個人需求量身定做。因此，老年人更傾向於選擇生物植入物來增強身體和功能能力。

醫療技術不斷進步

生物材料、3D列印和組織工程等醫療技術的不斷進步是推動生物植入物市場成長的關鍵因素。生物材料的創新促進了生物相容性和耐用性增強的植入物的開發，降低了不良反應的風險。 3D 列印可精確客製化植入物，改善患者特定的治療效果並減少手術併發症。此外，組織工程技術為創建可與身體組織無縫整合的生物功能植入物開闢了途徑。這些技術進步擴大了生物植入物的應用和有效性，吸引了醫療保健專業人員和尋求先進和客製化醫療解決方案的患者。

患者對生物植入物益處的認知不斷提高

提高患者對生物植入物益處的認知是推動市場成長的關鍵驅動力。患者越來越了解生物植入物恢復正常身體功能、減輕疼痛和提高整體生活品質的潛力。透過網路和醫療保健活動獲取訊息，患者正在積極尋求為他們的醫療狀況提供長期解決方案的替代方案。透過生物植入獲得積極成果的個人的成功故事正在影響其他人考慮這些干預措施。這種意識的提高不僅提高了患者的接受度，還鼓勵醫療保健提供者推薦生物植入物作為可行的治療選擇，有助於市場的擴大。此外，患者意識的不斷增強促使醫療保健專業人員將生物植入作為其治療建議的一部分。醫生擴大考慮將生物植入物作為各個專業的有效治療選擇。患者利益和醫療認可之間的這種一致性創造了一個積極的反饋循環，推動生物植入物的更多採用並促進市場成長。

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球生物植入物市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場區隔：依生物植入物類型
  • 市場區隔：按材料
  • 市場區隔：按產地
  • 市場區隔：依管理模式
  • 市場區隔：按最終用戶
  • 市場區隔：按地區
  • 市場預測

第 6 章：市場細分：依生物植入物類型

  • 心血管植入物
    • 市場走向
    • 市場預測
  • 植牙
    • 市場走向
    • 市場預測
  • 脊椎生物植入物
    • 市場走向
    • 市場預測
  • 骨科植入物
    • 市場走向
    • 市場預測
  • 眼科植入物
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 7 章：市場區隔：依材料

  • 金屬色
    • 市場走向
    • 市場預測
  • 陶瓷製品
    • 市場走向
    • 市場預測
  • 聚合物
    • 市場走向
    • 市場預測
  • 生物
    • 市場走向
    • 市場預測

第 8 章：市場區隔：依來源地

  • 同種異體移植物
    • 市場走向
    • 市場預測
  • 自體移植物
    • 市場走向
    • 市場預測
  • 異種移植
    • 市場走向
    • 市場預測
  • 合成的
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按管理模式

  • 非手術
    • 市場走向
    • 市場預測
  • 外科
    • 市場走向
    • 市場預測

第 10 章：市場區隔：依最終用戶

  • 門診手術中心
    • 市場走向
    • 市場預測
  • 診所
    • 市場走向
    • 市場預測
  • 醫院
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 11 章：市場區隔：按地區

  • 北美洲
    • 市場走向
    • 市場預測
  • 歐洲
    • 市場走向
    • 市場預測
  • 亞太地區
    • 市場走向
    • 市場預測
  • 中東和非洲
    • 市場走向
    • 市場預測
  • 拉丁美洲
    • 市場走向
    • 市場預測

第 12 章：全球生物植入物產業：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 13 章：全球生物植入物產業：價值鏈分析

  • 概述
  • 研究與開發
  • 原物料採購
  • 製造業
  • 行銷
  • 分配
  • 最終用途

第 14 章：全球生物植入物產業：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 15 章：全球生物植入物產業：價格分析

  • 價格指標
  • 價格結構
  • 利潤分析

第 16 章：生物植入物製造過程

  • 產品概述
  • 原料要求
  • 製造流程
  • 關鍵成功因素與風險因素

第17章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • Boston Scientific Corporation
    • Stryker Corporation
    • St. Jude Medical Inc
    • Medtronic Inc.
    • Smith and Nephew
    • Wright Medical Group
    • Zimmer Biomet
    • Dentsply Sirona
    • Invibio Limited
    • Straumann
    • Danaher Corporation
    • Cardinal Health
    • Johnson & Johnson
    • B. Braun Melsungen
    • LifeNet Health, Inc
    • Endo International plc
Product Code: SR112024A1162

Abstract

The global bio-implants market size reached US$ 126.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 242.7 Billion by 2032, exhibiting a growth rate (CAGR) of 7.3% during 2024-2032. The rising geriatric population around the world, constant advancements in medical technology, including biomaterials, 3D printing, and tissue engineering, and the growing awareness among patients about the benefits of bio-implants are some of the major factors propelling the market.

Bio-implants, also known as biomedical implants or medical implants, are devices or materials that are surgically implanted into the body to replace, support, or enhance a biological structure or function. These implants are designed to interact with living tissues, promoting integration and compatibility to achieve specific medical objectives. Bio-implants can vary widely in terms of their composition, purpose, and applications. They are commonly used in various medical fields, including orthopedics, cardiology, dentistry, neurology, and cosmetic surgery. They can also replace damaged or dysfunctional body parts or structures. For instance, joint replacements (such as hip or knee implants) are used to restore mobility and alleviate pain in individuals with joint degeneration.

The increasing geriatric population is primarily driving the market as they often require medical interventions for various health conditions. Bio-implants, such as joint replacements and dental implants, play a critical role in restoring mobility and enhancing quality of life for older adults. In addition, constant advancements in medical technology, including biomaterials, 3D printing, and tissue engineering, have enabled the development of innovative and sophisticated bio-implants. These technologies lead to improved implant durability, functionality, and biocompatibility. Moreover, the growing prevalence of chronic diseases, such as cardiovascular diseases, diabetes, and orthopedic disorders is also escalating the demand for bio-implants. These implants are often required for treatment, rehabilitation, and restoration of normal bodily functions. Moreover, growing awareness among patients about the benefits of bio-implants and their effectiveness in improving health outcomes has led to greater acceptance and demand for these medical devices.

Bio-Implants Market Trends/Drivers:

Rising geriatric population around the world

The global rise in the geriatric population is a significant driver fueling the growth of the bio-implants market. As the elderly population increases, the prevalence of age-related medical conditions such as joint degeneration, cardiovascular diseases, and dental issues also rises. Bio-implants play a vital role in addressing these conditions by providing solutions like joint replacements, cardiac implants, and dental prosthetics. As a result, the need to enhance the quality of life and restore functional independence among seniors drives the demand for bio-implants, contributing to market expansion. Moreover, with advancements in medical technology, these implants are becoming increasingly sophisticated, durable, and tailored to individual patient needs. As a result, the elderly population is more inclined to opt for bio-implants to enhance their physical and functional capabilities.

Constant advancements in medical technology

The continuous progress in medical technology, encompassing biomaterials, 3D printing, and tissue engineering, is a pivotal factor driving the growth of the bio-implants market. Innovations in biomaterials have led to the development of implants with enhanced biocompatibility and durability, reducing the risk of adverse reactions. 3D printing enables precise customization of implants, improving patient-specific outcomes and reducing surgical complications. Moreover, tissue engineering techniques have opened avenues for creating biologically functional implants that can integrate seamlessly with the body's tissues. These technological advancements have expanded the applications and effectiveness of bio-implants, attracting both healthcare professionals and patients seeking advanced and tailored medical solutions.

Growing awareness among patients about the benefits of bio-implants

Increasing patient awareness about the benefits of bio-implants is a key driver propelling market growth. Patients are becoming more informed about the potential of bio-implants to restore normal bodily functions, alleviate pain, and enhance overall quality of life. With access to information through the internet and healthcare campaigns, patients are actively seeking alternatives that offer long-term solutions to their medical conditions. The success stories of individuals who have experienced positive outcomes with bio-implants are influencing others to consider these interventions. This heightened awareness has not only boosted patient acceptance but also encouraged healthcare providers to recommend bio-implants as viable treatment options, thereby contributing to the expansion of the market. Furthermore, the growing awareness among patients has prompted healthcare professionals to include bio-implants as part of their treatment recommendations. Medical practitioners are increasingly considering bio-implants as effective therapeutic options across various specialties. This alignment between patient interest and medical endorsement creates a positive feedback loop, driving greater adoption of bio-implants and contributing to market growth.

Bio-Implants Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global bio-implants market report, along with forecasts at the global and regional levels for 2024-2032. Our report has categorized the market based on type of bio-implants, material, origin, mode of administration and end user.

Breakup by Type of Bio-Implants:

Cardiovascular Implants

Dental Implants

Spinal Bio-implants

Orthopaedic Implants

Ophthalmic Implants

Others

Orthopaedic implants represent the most used type of bio-implant

The report has provided a detailed breakup and analysis of the market based on the type of bio-implants. This includes cardiovascular implants, dental implants, spinal bio-implants, orthopaedic implants, ophthalmic implants and others. According to the report, orthopaedic implants represented the largest segment.

Orthopedic implants are widely used to address a range of musculoskeletal disorders, including joint degeneration, fractures, and bone deformities. The prevalence of conditions such as osteoarthritis and fractures, especially among the aging population, drives the demand for orthopedic implants. Moreover, they offer patients the ability to regain mobility, reduce pain, and improve overall functionality. This positive impact on patients' quality of life encourages greater acceptance of orthopedic implant procedures. Besides, constant advancements in orthopedic implant technology, including improved biomaterials, design innovation, and minimally invasive surgical techniques, have made orthopedic procedures more effective and patient-friendly. These advancements contribute to the widespread use and success of orthopedic implants.

Breakup by Material:

Metallic

Ceramic

Polymer

Biological

A detailed breakup and analysis of the market based on the material has also been provided in the report. This includes metallic, ceramic, polymer and biological.

Metallic implants are widely utilized in various medical applications due to their strength, durability, and compatibility with the human body. Materials like titanium and stainless steel are commonly used for joint replacements, orthopedic implants, and dental fixtures. Metallic implants offer excellent load-bearing capabilities, making them suitable for weight-bearing structures within the body.

Ceramic implants are known for their biocompatibility, resistance to wear, and ability to closely mimic natural tissues. Materials such as alumina and zirconia are often used for dental implants and joint replacements. They are valued for their aesthetic appeal, as they can resemble natural teeth and bones, enhancing patient satisfaction.

Polymer implants are lightweight and can be tailored to specific requirements. They are commonly used in non-weight-bearing applications, such as soft tissue repair, cardiovascular devices, and cosmetic enhancements. Polymers like polyethylene and polyurethane are chosen for their flexibility, corrosion resistance, and ability to minimize stress on surrounding tissues.

Biological implants involve the use of tissues or cells sourced from human or animal donors. These implants include materials like allografts (donor tissues), xenografts (animal tissues), and autografts (the patient's own tissues). These implants are utilized for grafts, transplants, and regenerative procedures. They offer the advantage of potentially seamless integration with the patient's body.

Breakup by Origin:

Allograft

Autograft

Xenograft

Synthetic

Xenograft accounts for the majority of market share

A detailed breakup and analysis of the market based on the origin has also been provided in the report. This includes allograft, autograft, xenograft and synthetic. According to the report, xenograft accounted for the largest market share.

Xenografts benefit from a readily available and sustainable supply of biological tissues, primarily sourced from animals such as pigs and cows. This abundant supply helps meet the demand for bio-implants without significant limitations, which can be particularly advantageous when addressing large patient populations. Moreover, they are processed to reduce the risk of immune rejection and adverse reactions when implanted in humans. While some immune response mitigation might still be necessary, advancements in processing techniques have significantly improved xenograft biocompatibility, making them suitable for a wide range of applications. Besides, xenografts often offer cost-effective solutions compared to other types of bio-implants, making them an attractive option for both patients and healthcare systems seeking high-quality medical interventions without exorbitant costs.

Breakup by Mode of Administration:

Non-Surgical

Surgical

A detailed breakup and analysis of the market based on the mode of administration has also been provided in the report. This includes non-surgical and surgical.

Non-surgical bio-implants involve methods of implantation that do not require invasive surgical procedures. Instead, they often rely on minimally invasive techniques or external applications. Examples of non-surgical bio-implants include wearable medical devices, such as insulin pumps for diabetes management or hearing aids for auditory support. These devices are designed to be worn or attached externally to the body and can provide continuous monitoring, drug delivery, or functional enhancement without the need for surgical intervention.

Surgical bio-implants involve procedures that require a surgical incision to place the implant directly within the body. These types of implants are commonly used for structural support, replacement, or enhancement of biological tissues or organs. Surgical bio-implants encompass a wide range of applications, including joint replacements (e.g., hip or knee implants), cardiovascular implants (e.g., stents or pacemakers), dental implants, and various orthopedic devices. They often provide long-term solutions to medical conditions and are integrated into the body's anatomical structures through surgical procedures.

Breakup by End User:

Ambulatory Surgical Centers

Clinics

Hospital

Others

Hospitals are the leading end users in the market

A detailed breakup and analysis of the market based on the end user has also been provided in the report. This includes ambulatory surgical centers, clinics, hospital, and others. According to the report, hospitals accounted for the largest market share.

Hospitals house a diverse range of medical specialists, including surgeons, orthopedists, cardiologists, and dentists. These experts are trained to diagnose, recommend, and perform surgical procedures that involve the use of bio-implants. The presence of skilled healthcare professionals ensures that implants are correctly selected, implanted, and monitored for optimal patient outcomes. Moreover, hospitals are equipped with state-of-the-art surgical facilities, including operating rooms, advanced imaging technologies, and post-operative care units. These facilities are essential for performing complex implant surgeries safely and efficiently, ensuring the best possible results for patients.

Breakup by Region:

North America

Asia Pacific

Europe

Latin America

Middle East and Africa

North America exhibits a clear dominance in the market

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to the report, North America accounted for the largest market share.

North America boasts a well-developed and advanced healthcare infrastructure, including modern hospitals, research institutions, and medical universities. This infrastructure supports the adoption of innovative medical technologies, including bio-implants, and facilitates their integration into clinical practice. Moreover, the region's substantial healthcare expenditure allows for significant investments in medical research, technology, and patient care. This financial commitment enables healthcare providers to offer a wide range of advanced medical interventions, including bio-implants, to patients. Besides, stringent regulatory standards and thorough approval processes ensure the safety and efficacy of medical devices, including bio-implants, in North America. This regulatory framework instills confidence among healthcare professionals and patients, promoting the adoption of bio-implant technologies.

Competitive Landscape:

The competitive landscape of the market is characterized by the presence of multiple players that include established brands, emerging startups, and specialty manufacturers. Presently, leading companies are investing significantly in R&D to develop advanced bio-implants that incorporate cutting-edge technologies, biomaterials, and design methodologies. These developments aim to improve implant durability, biocompatibility, and functionality. They are also expanding their product offerings to cover a broader spectrum of medical needs. This includes developing a range of bio-implants for different anatomical sites, medical conditions, and patient demographics. Moreover, to meet individual patient requirements, some companies are focusing on offering personalized bio-implant solutions. They use techniques like 3D printing and computer-aided design to create implants tailored to a patient's unique anatomy and needs.

The market research report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Abbott Laboratories

Boston Scientific Corporation

Stryker Corporation

St. Jude Medical Inc

Medtronic Inc.

Smith and Nephew

Wright Medical Group

Zimmer Biomet

Dentsply Sirona

Invibio Limited

Straumann

Danaher Corporation

Cardinal Health

Johnson & Johnson

B. Braun Melsungen

LifeNet Health, Inc

Endo International plc

Recent Developments:

Medtronic Inc. has introduced implantable devices that can communicate wirelessly with smartphones or other external devices, enabling patients and healthcare professionals to monitor and manage implant performance remotely.

Stryker corporation introduced a novel bio-implant for spinal fusion surgeries. This implant features an innovative design that enhances stability and promotes better fusion between vertebrae, addressing patients' needs for improved spinal health.

Zimmer Biomet developed a customizable knee implant system using 3D printing technology. This system allows surgeons to create patient-specific knee implants that match the patient's unique anatomy, potentially leading to better post-operative outcomes.

Key Questions Answered in This Report

  • 1. What was the size of the global bio-implants market in 2023?
  • 2. What is the expected growth rate of the global bio-implants market during 2024-2032?
  • 3. What are the key factors driving the global bio-implants market?
  • 4. What has been the impact of COVID-19 on the global bio-implants market?
  • 5. What is the breakup of the global bio-implants market based on the type of bio-implants?
  • 6. What is the breakup of the global bio-implants market based on the origin?
  • 7. What is the breakup of the global bio-implants market based on the end-user?
  • 8. What are the key regions in the global bio-implants market?
  • 9. Who are the key players/companies in the global bio-implants market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Bio-Implants Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Type of Bio-Implants
  • 5.5 Market Breakup by Material
  • 5.6 Market Breakup by Origin
  • 5.7 Market Breakup by Mode of Administration
  • 5.8 Market Breakup by End-User
  • 5.9 Market Breakup by Region
  • 5.10 Market Forecast

6 Market Breakup by Type of Bio-Implants

  • 6.1 Cardiovascular Implants
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Dental Implants
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Spinal Bio-implants
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Orthopaedic Implants
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Ophthalmic Implants
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Material

  • 7.1 Metallic
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Ceramic
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Polymer
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Biological
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Origin

  • 8.1 Allograft
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Autograft
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Xenograft
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Synthetic
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Mode of Administration

  • 9.1 Non Surgical
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Surgical
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by End-User

  • 10.1 Ambulatory Surgical Centers
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Clinics
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Hospital
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Others
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 Market Trends
    • 11.1.2 Market Forecast
  • 11.2 Europe
    • 11.2.1 Market Trends
    • 11.2.2 Market Forecast
  • 11.3 Asia Pacific
    • 11.3.1 Market Trends
    • 11.3.2 Market Forecast
  • 11.4 Middle East and Africa
    • 11.4.1 Market Trends
    • 11.4.2 Market Forecast
  • 11.5 Latin America
    • 11.5.1 Market Trends
    • 11.5.2 Market Forecast

12 Global Bio-Implants Industry: SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Global Bio-Implants Industry: Value Chain Analysis

  • 13.1 Overview
  • 13.2 Research and Development
  • 13.3 Raw Material Procurement
  • 13.4 Manufacturing
  • 13.5 Marketing
  • 13.6 Distribution
  • 13.7 End-Use

14 Global Bio-Implants Industry: Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Global Bio-Implants Industry: Price Analysis

  • 15.1 Price Indicators
  • 15.2 Price Structure
  • 15.3 Margin Analysis

16 Bio-Implants Manufacturing Process

  • 16.1 Product Overview
  • 16.2 Raw Material Requirements
  • 16.3 Manufacturing Process
  • 16.4 Key Success and Risk Factors

17 Competitive Landscape

  • 17.1 Market Structure
  • 17.2 Key Players
  • 17.3 Profiles of Key Players
    • 17.3.1 Abbott Laboratories
    • 17.3.2 Boston Scientific Corporation
    • 17.3.3 Stryker Corporation
    • 17.3.4 St. Jude Medical Inc
    • 17.3.5 Medtronic Inc.
    • 17.3.6 Smith and Nephew
    • 17.3.7 Wright Medical Group
    • 17.3.8 Zimmer Biomet
    • 17.3.9 Dentsply Sirona
    • 17.3.10 Invibio Limited
    • 17.3.11 Straumann
    • 17.3.12 Danaher Corporation
    • 17.3.13 Cardinal Health
    • 17.3.14 Johnson & Johnson
    • 17.3.15 B. Braun Melsungen
    • 17.3.16 LifeNet Health, Inc
    • 17.3.17 Endo International plc

List of Figures

  • Figure 1: Global: Bio-Implants Market: Major Drivers and Challenges
  • Figure 2: Global: Bio-Implants Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Bio-Implants Market: Breakup by Type of Bio-Implants (in %), 2023
  • Figure 4: Global: Bio-Implants Market: Breakup by Material (in %), 2023
  • Figure 5: Global: Bio-Implants Market: Breakup by Origin (in %), 2023
  • Figure 6: Global: Bio-Implants Market: Breakup by Mode of Administration (in %), 2023
  • Figure 7: Global: Bio-Implants Market: Breakup by End-User (in %), 2023
  • Figure 8: Global: Bio-Implants Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Bio-Implants Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 10: Global: Bio-Implants Industry: SWOT Analysis
  • Figure 11: Global: Bio-Implants Industry: Value Chain Analysis
  • Figure 12: Global: Bio-Implants Industry: Porter's Five Forces Analysis
  • Figure 13: Global: Bio-Implants (Cardiovascular Implants) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Bio-Implants (Cardiovascular Implants) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Bio-Implants (Dental Implants) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Bio-Implants (Dental Implants) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Bio-Implants (Spinal Bio-implants) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Bio-Implants (Spinal Bio-implants) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Bio-Implants (Orthopaedic Implants) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Bio-Implants (Orthopaedic Implants) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Bio-Implants (Ophthalmic Implants) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Bio-Implants (Ophthalmic Implants) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Bio-Implants (Other Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Bio-Implants (Other Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Bio-Implants (Metallic) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Bio-Implants (Metallic) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Bio-Implants (Ceramic) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Bio-Implants (Ceramic) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Bio-Implants (Polymer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Bio-Implants (Polymer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Bio-Implants (Biological) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Bio-Implants (Biological) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Bio-Implants (Allograft) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Bio-Implants (Allograft) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Bio-Implants (Autograft) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Bio-Implants (Autograft) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Bio-Implants (Xenograft) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Bio-Implants (Xenograft) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Global: Bio-Implants (Synthetic) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Global: Bio-Implants (Synthetic) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Global: Bio-Implants (Non Surgical) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Global: Bio-Implants (Non Surgical) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Global: Bio-Implants (Surgical) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Global: Bio-Implants (Surgical) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Global: Bio-Implants (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Global: Bio-Implants (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Global: Bio-Implants (Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Global: Bio-Implants (Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Global: Bio-Implants (Hospital) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Global: Bio-Implants (Hospital) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Global: Bio-Implants (Other End-Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Global: Bio-Implants (Other End-Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: North America: Bio-Implants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: North America: Bio-Implants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Europe: Bio-Implants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Europe: Bio-Implants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Asia Pacific: Bio-Implants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Asia Pacific: Bio-Implants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Middle East and Africa: Bio-Implants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Middle East and Africa: Bio-Implants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Latin America: Bio-Implants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Latin America: Bio-Implants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Bio-Implants Manufacturing: Process Flow

List of Tables

  • Table 1: Global: Bio-Implants Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Bio-Implants Market Forecast: Breakup by Type of Bio-Implants (in Million US$), 2024-2032
  • Table 3: Global: Bio-Implants Market Forecast: Breakup by Material (in Million US$), 2024-2032
  • Table 4: Global: Bio-Implants Market Forecast: Breakup by Origin (in Million US$), 2024-2032
  • Table 5: Global: Bio-Implants Market Forecast: Breakup by Mode of Administration (in Million US$), 2024-2032
  • Table 6: Global: Bio-Implants Market Forecast: Breakup by End-User (in Million US$), 2024-2032
  • Table 7: Global: Bio-Implants Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 8: Bio-Implants: Raw Material Requirements
  • Table 9: Global: Bio-Implants Market Structure
  • Table 10: Global: Bio-Implants Market: Key Players